These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 10697560

  • 1. Cytotoxicity of L-cycloserine against human neuroblastoma and medulloblastoma cells is associated with the suppression of ganglioside expression.
    Cinatl J, Cinatl J, Kotchetkov R, Pouckova P, Vogel JU, Rabenau H, Michaelis M, Kornhuber B.
    Anticancer Res; 1999; 19(6B):5349-54. PubMed ID: 10697560
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts.
    Evans AE, Kisselbach KD, Yamashiro DJ, Ikegaki N, Camoratto AM, Dionne CA, Brodeur GM.
    Clin Cancer Res; 1999 Nov; 5(11):3594-602. PubMed ID: 10589776
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
    Ohta S, Igarashi S, Honda A, Sato S, Hanai N.
    Anticancer Res; 1993 Nov; 13(2):331-6. PubMed ID: 8517645
    [Abstract] [Full Text] [Related]

  • 4. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
    Vrionis FD, Wikstrand CJ, Fredman P, Månsson JE, Svennerholm L, Bigner DD.
    Cancer Res; 1989 Dec 01; 49(23):6645-51. PubMed ID: 2479468
    [Abstract] [Full Text] [Related]

  • 5. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.
    Cinatl J, Cinatl J, Kotchetkov R, Matousek J, Woodcock BG, Koehl U, Vogel JU, Kornhuber B, Schwabe D.
    Anticancer Res; 2000 Dec 01; 20(2A):853-9. PubMed ID: 10810366
    [Abstract] [Full Text] [Related]

  • 6. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.
    Shurin GV, Shurin MR, Bykovskaia S, Shogan J, Lotze MT, Barksdale EM.
    Cancer Res; 2001 Jan 01; 61(1):363-9. PubMed ID: 11196188
    [Abstract] [Full Text] [Related]

  • 7. Shedding of gangliosides by human medulloblastoma cells.
    Chang F, Li R, Ladisch S.
    Exp Cell Res; 1997 Aug 01; 234(2):341-6. PubMed ID: 9260903
    [Abstract] [Full Text] [Related]

  • 8. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.
    Mujoo K, Kipps TJ, Yang HM, Cheresh DA, Wargalla U, Sander DJ, Reisfeld RA.
    Cancer Res; 1989 Jun 01; 49(11):2857-61. PubMed ID: 2720646
    [Abstract] [Full Text] [Related]

  • 9. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
    Kowalczyk A, Gil M, Horwacik I, Odrowaz Z, Kozbor D, Rokita H.
    Cancer Lett; 2009 Aug 28; 281(2):171-82. PubMed ID: 19339105
    [Abstract] [Full Text] [Related]

  • 10. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
    Cheung NK, Modak S.
    Clin Cancer Res; 2002 May 28; 8(5):1217-23. PubMed ID: 12006541
    [Abstract] [Full Text] [Related]

  • 11. Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines.
    Yamashiro S, Ruan S, Furukawa K, Tai T, Lloyd KO, Shiku H, Furukawa K.
    Cancer Res; 1993 Nov 15; 53(22):5395-400. PubMed ID: 8221677
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
    Poljaková J, Eckschlager T, Hrabeta J, Hrebacková J, Smutný S, Frei E, Martínek V, Kizek R, Stiborová M.
    Biochem Pharmacol; 2009 May 01; 77(9):1466-79. PubMed ID: 19426684
    [Abstract] [Full Text] [Related]

  • 18. N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
    Baek RC, Kasperzyk JL, Platt FM, Seyfried TN.
    Neurochem Int; 2008 May 01; 52(6):1125-33. PubMed ID: 18207611
    [Abstract] [Full Text] [Related]

  • 19. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F, Brignole C, Marimpietri D, Di Paolo D, Zancolli M, Pagnan G, Ponzoni M.
    Ann N Y Acad Sci; 2004 Dec 01; 1028():90-103. PubMed ID: 15650235
    [Abstract] [Full Text] [Related]

  • 20. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F, Brignole C, Marimpietri D, Sapra P, Moase EH, Allen TM, Ponzoni M.
    Cancer Res; 2003 Jan 01; 63(1):86-92. PubMed ID: 12517782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.